Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.
Umberto Tachinardi (left) and Peter Embi (right) N3C honest data broker leaders

Two Regenstrief Institute leaders will share their expertise on infrastructure and ethical considerations related to real-world data and evidence in healthcare at the 2021 Precision Health Virtual Summit. 

Regenstrief President and Chief Executive Officer and Indiana University School of Medicine Associate Dean for Informatics and Health Services Research Peter Embí, M.D., M.S., and Regenstrief Chief Information Officer and IU School of Medicine Assistant Dean for Clinical Informatics Umberto Tachinardi, M.D., MSc, are speaking at the event hosted by hc1 and Becker’s Healthcare on August 31 and September 1, 2021.  

The virtual event brings together healthcare leaders and industry experts to focus on making precision health achievable and accessible to everyone in all aspects of care delivery. Precision health takes into account each patient’s individual characteristics to provide better tools to understand the best strategies to help the patient stay healthy or treat them when they are sick.  

Dr. Embí and Dr. Tachinardi will present during a breakout session on August 31 titled “Emerging Ideas: Advancing Real World Data and Evidence in Health: Infrastructure and Ethical Considerations.”  

Dr. Embí is internationally recognized for his work in clinical and translational research informatics. He leads a learning health initiative that uses data from every patient encounter to create real world data and evidence to improve care. He also believes in the importance of constantly monitoring and evaluating healthcare artificial intelligence algorithms for unintended consequences.  

Dr. Tachinardi has a history of successfully developing and implementing health informatics technologies in organizations of all sizes. He works to create tools and technologies to leverage real world data and enable health professionals to provide precision health.  

Registration for the Precision Health Virtual Summit hosted by hc1 and Becker’s Healthcare is free.

Sign up here

About Regenstrief Institute 

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.  

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.  

About hc1  

hc1 is the leader in critical insight, analytics, and solutions for precision health. The hc1 Precision Health Cloud®  organizes volumes of live data, including lab results, genomics, and medications, to deliver solutions that ensure that the right patient gets the right test and the right prescription at the right time. Today, hc1 powers solutions that optimize diagnostic testing and prescribing for millions of patients nationally.  To learn more about hc1’s proven approach to personalizing care while eliminating waste for thousands of health systems, diagnostic laboratories, and health plans, visit www.hc1.com.  

About Becker’s Healthcare 

Becker’s Healthcare is the go-to source for healthcare decision-makers and one of the fastest growing media platforms in the industry. Through print, digital and live event platforms, Becker’s Healthcare equips healthcare leaders with the information and forums they need to learn, exchange ideas and further conversations about the most critical issues in American healthcare. 

About IU School of Medicine  

IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability. 

About Peter Embí, M.D., M.S.  

In addition to serving as the president and CEO of Regenstrief Institute, Peter Embí, M.D., M.S. is the Leonard Betley Professor of Medicine and associate dean for informatics and health services research at Indiana University School of Medicine, associate director of informatics with Indiana Clinical and Translational Sciences Institute and vice president for Learning Health Systems with Indiana University Health. 

About Umberto Tachinardi, M.D., MSc  

In addition to being the chief information officer at Regenstrief Institute, Umberto Tachinardi, M.D., MSc, is the director of clinical research informatics for Regenstrief and the Indiana Clinical and Translational Sciences Institute and the chief informatics officer for the Indiana University Grand Challenge Precision Health Initiative. He is also the assistant dean for clinical informatics and a professor of biostatistics at Indiana University School of Medicine. 

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313

Related News

Nov 16, 2021 • News
Study tackles reducing bladder cancer recurrence
National and international guidelines call for administration of postoperative immediate chemotherapy to reduce recurrence of non-muscle invasive bladder cancer. Yet this is done in less than half of cases. A new study led by Clint Cary, M.D., MPH, of the Regenstrief Institute and Indiana University School of Medicine, explores environmental barriers to implementation of these…
Continue Reading >
Nov 15, 2021 • News
No FIT: Colon cancer screening FIT doesn’t belong in emergency and inpatient settings
FIT and other cancer screening tests not designed for diagnosis A clinical research study from Indiana University School of Medicine and the Regenstrief Institute examines the use, in emergency and inpatient settings, of FIT (fecal immunochemical testing), which looks for blood in stool, a possible sign of colorectal cancer. The researchers conclude that FIT should…
Continue Reading >